TechCrunch: FDA approves esketamine nasal spray, the first new major depression drug in more than 30 years

In one of the most significant milestones for depression treatment in decades, the U.S. Food and Drug Administration announced today that it has approved a new drug with esketamine, a derivative of ketamine. Made by Johnson & Johnson under the…

TechCrunch: Mental well-being took center stage at CES 2019

This week, the Las Vegas Convention Center was packed with many of the year’s biggest new devices. But over the last several years, The Sands has become the place where the real magic happens. The segment of the show known…